Quick Answer
PLIANT THERAPEUTICS, INC. reported Total Revenue of $0.00 for fiscal year 2025.
PLIANT THERAPEUTICS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | — |
| 2024 | $0.00 | -100.0% |
| 2023 | $1.58M | -83.7% |
| 2022 | $9.69M | +27.9% |
| 2021 | $7.57M | -81.9% |
| 2020 | $41.82M | -26.7% |
| 2019 | $57.05M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | -100.0% | -100.0% |
| June 30, 2023 | $248.0K | -95.0% | -81.4% |
| March 31, 2023 | $1.33M | +6.6% | -10.1% |
| September 30, 2022 | $1.48M | -8.0% | -70.3% |
| June 30, 2022 | $4.99M | +178.9% | +299.4% |
- Over the 2019–2025 period, PLIANT THERAPEUTICS, INC.’s total revenue has declined by 100.0% (from $57.05 million to $0.00).
- The most recent figure is from PLIANT THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: